Cite Filings / FTH / 0001193125-26-279412
Feed Companies Filings Check
Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Faeth Therapeutics, Inc. · Filed 2026-06-23 · Acc 0001193125-26-279412

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-08-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-06-26 4 Chief Financial Officer bought 15,641 shares at an average $25.65 ($401,269)
  • 2026-06-24 4 President and CEO bought 2,806 shares at $19.76 ($55,447)
  • 2026-06-24 4 Chief Financial Officer bought 17,413 shares at an average $23.31 ($405,921)
  • 2026-06-23 3 Initial Statement of Ownership
  • 2026-06-23 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-06-23 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-17 SCHEDULE 13G · Trails Edge Capital Partners, LP 5.4%
  2. 2026-11-16 SCHEDULE 13G · Avoro Capital Advisors LLC 5.46%
  3. 2026-11-13 SCHEDULE 13G/A · Montanova Capital, LLC 8.9%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…